Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Decreases By 98.0%

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 44,035 shares, a decrease of 98.0% from the April 30th total of 2,166,796 shares. Currently, 0.7% of the shares of the company are sold short. Based on an average daily trading volume, of 9,850,067 shares, the short-interest ratio is currently 0.0 days.

Institutional Trading of GlucoTrack

A number of hedge funds have recently modified their holdings of GCTK. Ikarian Capital LLC acquired a new stake in GlucoTrack during the fourth quarter worth about $177,000. Boothbay Fund Management LLC acquired a new position in GlucoTrack in the fourth quarter valued at approximately $52,000. Finally, Bank of America Corp DE boosted its position in GlucoTrack by 102,125.0% in the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares in the last quarter. Hedge funds and other institutional investors own 10.92% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of GlucoTrack in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

GlucoTrack Stock Performance

NASDAQ:GCTK traded up $0.01 during mid-day trading on Friday, hitting $0.66. The company’s stock had a trading volume of 401,532 shares, compared to its average volume of 3,085,490. The business’s fifty day moving average is $0.77 and its two-hundred day moving average is $2.58. The stock has a market cap of $4.13 million, a price-to-earnings ratio of -0.04 and a beta of 0.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.85 and a quick ratio of 0.85. GlucoTrack has a 1 year low of $0.43 and a 1 year high of $15.90.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.